je.st
news
Teva offers to buy Mylan in $40.1B cash-and-stock deal
2015-04-21 17:05:03| Biotech - Topix.net
Teva has offered to buy Mylan for about $40.1 billion in cash and stock in a deal that would create a powerhouse of generic drug development. If Teva manages to acquire Mylan under the offer announced Tuesday, it would help Teva secure a more dominant position as it would be taking Mylan off of a growing list of competitors.
Tags: buy
offers
deal
teva
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||